{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:10:34Z","timestamp":1791141034524,"version":"4.1.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type 2A VWD is characterized by the absence of large VWF multimers and decreased platelet-binding function. Historically, type 2A variants are subdivided into group 1, which have impaired assembly and secretion of VWF multimers, or group 2, which have normal secretion of VWF multimers and increased ADAMTS13 proteolysis. Type 2A VWD patients recruited through the T. S. Zimmerman Program for the Molecular and Clinical Biology of VWD study were characterized phenotypically and potential mutations identified in the VWF D2, D3, A1, and A2 domains. We examined type 2A variants and their interaction with WT-VWF through expression studies. We assessed secretion\/intracellular retention, multimerization, regulated storage, and ADAMTS13 proteolysis. Whereas some variants fit into the traditional group 1 or 2 categories, others did not fall clearly into either category. We determined that loss of Weibel-Palade body formation is associated with markedly reduced secretion. Mutations involving cysteines were likely to cause abnormalities in multimer structure but not necessarily secretion. When coexpressed with wild-type VWF, type 2A variants negatively affected one or more mechanisms important for normal VWF processing. Type 2A VWD appears to result from a complex intersection of mechanisms that include: (1) intracellular retention or degradation of VWF, (2) defective multimerization, (3) loss of regulated storage, and (4) increased proteolysis by ADAMTS13.<\/jats:p>","DOI":"10.1182\/blood-2011-06-360875","type":"journal-article","created":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T05:21:23Z","timestamp":1332220883000},"page":"4543-4553","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":56,"title":["Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage"],"prefix":"10.1182","volume":"119","author":[{"given":"Paula M.","family":"Jacobi","sequence":"first","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Cox","family":"Gill","sequence":"additional","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI;"},{"name":"Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI; and"},{"name":"Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica H.","family":"Flood","sequence":"additional","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI;"},{"name":"Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI; and"},{"name":"Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Jakab","sequence":"additional","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI;"},{"name":"Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Haberichter","sequence":"additional","affiliation":[{"name":"Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI;"},{"name":"Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI; and"},{"name":"Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2019111808512889400_B1","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1073\/pnas.71.5.1906","article-title":"Synthesis of von Willebrand factor by cultured human endothelial cells.","volume":"71","author":"Jaffe","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111808512889400_B2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.95.1.355","article-title":"Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells.","volume":"95","author":"Wagner","year":"1982","journal-title":"J Cell Biol"},{"issue":"8","key":"2019111808512889400_B3","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/j.1460-2075.1986.tb04435.x","article-title":"Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit.","volume":"5","author":"Verweij","year":"1986","journal-title":"EMBO J"},{"key":"2019111808512889400_B4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor.","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"issue":"1","key":"2019111808512889400_B5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V69.1.27.bloodjournal69127","article-title":"Topology and order of formation of interchain disulfide bonds in von Willebrand factor.","volume":"69","author":"Wagner","year":"1987","journal-title":"Blood"},{"issue":"3","key":"2019111808512889400_B6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/j.1460-2075.1990.tb08176.x","article-title":"Domains involved in multimer assembly of von willebrand factor (vWF): multimerization is independent of dimerization.","volume":"9","author":"Voorberg","year":"1990","journal-title":"EMBO J"},{"issue":"11","key":"2019111808512889400_B7","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1021\/bi00359a015","article-title":"Amino acid sequence of human von Willebrand factor.","volume":"25","author":"Titani","year":"1986","journal-title":"Biochemistry"},{"issue":"12","key":"2019111808512889400_B8","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1182\/blood.V83.12.3536.3536","article-title":"von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies.","volume":"83","author":"Vischer","year":"1994","journal-title":"Blood"},{"issue":"13","key":"2019111808512889400_B9","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1016\/S0021-9258(19)50338-6","article-title":"Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures.","volume":"267","author":"Matsui","year":"1992","journal-title":"J Biol Chem"},{"issue":"23","key":"2019111808512889400_B10","doi-asserted-by":"crossref","first-page":"9378","DOI":"10.1073\/pnas.87.23.9378","article-title":"Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site.","volume":"87","author":"Wise","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111808512889400_B11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2004-02-0464","article-title":"Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.","volume":"105","author":"Haberichter","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111808512889400_B12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1182\/blood.V66.3.710.710","article-title":"Eccentric localization of von Willebrand factor in an internal structure of platelet alpha-granule resembling that of Weibel-Palade bodies.","volume":"66","author":"Cramer","year":"1985","journal-title":"Blood"},{"issue":"1","key":"2019111808512889400_B13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1172\/JCI9516","article-title":"Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.","volume":"106","author":"Kaufmann","year":"2000","journal-title":"J Clin Invest"},{"key":"2019111808512889400_B14","first-page":"707","article-title":"Structure and Function of von Willebrand Factor.","volume-title":"Hemostasis and Thrombosis - Basic Principles and Clinical Practice","author":"Haberichter","year":"2006","edition":"5th Ed"},{"issue":"10","key":"2019111808512889400_B15","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019111808512889400_B16","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V88.7.2433.bloodjournal8872433","article-title":"Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.","volume":"88","author":"Eikenboom","year":"1996","journal-title":"Blood"},{"issue":"5","key":"2019111808512889400_B17","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2002-03-0789","article-title":"The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF.","volume":"100","author":"Rosenberg","year":"2002","journal-title":"Blood"},{"issue":"1","key":"2019111808512889400_B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199701000-00001","article-title":"von Willebrand disease.","volume":"76","author":"Nichols","year":"1997","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2019111808512889400_B19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0609.1992.tb00584.x","article-title":"von Willebrand's disease.","volume":"48","author":"Holmberg","year":"1992","journal-title":"Eur J Haematol"},{"issue":"2","key":"2019111808512889400_B20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease.","volume":"84","author":"Sadler","year":"2000","journal-title":"Thromb Haemost"},{"issue":"6","key":"2019111808512889400_B21","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study.","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"issue":"7","key":"2019111808512889400_B22","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations.","volume":"267","author":"Lyons","year":"1992","journal-title":"J Biol Chem"},{"issue":"7","key":"2019111808512889400_B23","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1182\/blood.V87.7.2788.bloodjournal8772788","article-title":"Analysis of Arg834Gln and Val902Glu type 2A von Willebrand disease mutations: studies with recombinant von Willebrand factor and correlation with patient characteristics.","volume":"87","author":"Englender","year":"1996","journal-title":"Blood"},{"issue":"6","key":"2019111808512889400_B24","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2005-04-1758","article-title":"Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis.","volume":"107","author":"Hassenpflug","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2019111808512889400_B25","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V91.5.1572","article-title":"Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin-but not botrocetin-mediated binding of von Willebrand factor to platelets.","volume":"91","author":"Hillery","year":"1998","journal-title":"Blood"},{"issue":"4","key":"2019111808512889400_B26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1538-7836.2009.03290.x","article-title":"Genetic alteration of the D2 domain abolishes von Willebrand factor multimerization and trafficking into storage.","volume":"7","author":"Haberichter","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111808512889400_B27","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1182\/blood.V96.5.1808","article-title":"von Willebrand factor storage and multimerization: 2 independent intracellular processes.","volume":"96","author":"Haberichter","year":"2000","journal-title":"Blood"},{"issue":"6","key":"2019111808512889400_B28","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2010-08-299016","article-title":"Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.","volume":"117","author":"Flood","year":"2011","journal-title":"Blood"},{"issue":"22","key":"2019111808512889400_B29","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1182\/blood-2009-09-244327","article-title":"The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF.","volume":"115","author":"Haberichter","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111808512889400_B30","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2003-02-0599","article-title":"Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor.","volume":"102","author":"Michaux","year":"2003","journal-title":"Blood"},{"issue":"9","key":"2019111808512889400_B31","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1073\/pnas.88.9.3857","article-title":"Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis.","volume":"88","author":"Nichols","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2019111808512889400_B32","first-page":"350","article-title":"An additional unique candidate mutation (G2470A; M740I) in the original families with von Willebrand disease type 2 M Vicenza and the G3864A (R1205H) mutation.","volume":"84","author":"Castaman","year":"2000","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111808512889400_B33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2516.2008.01703.x","article-title":"L1503R is a member of group I mutation and has dominant-negative effect on secretion of full-length VWF multimers: an analysis of two patients with type 2A von Willebrand disease.","volume":"14","author":"Kashiwagi","year":"2008","journal-title":"Haemophilia"},{"issue":"10","key":"2019111808512889400_B34","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1538-7836.2009.03551.x","article-title":"An assessment of the pathogenic significance of the R924Q von Willebrand factor substitution.","volume":"7","author":"Berber","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111808512889400_B35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1538-7836.2005.01652.x","article-title":"Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretion.","volume":"4","author":"Hommais","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2019111808512889400_B36","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/j.1538-7836.2010.03971.x","article-title":"Homozygous type 2 N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype.","volume":"8","author":"Castaman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111808512889400_B37","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1182\/blood-2002-07-2281","article-title":"Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage.","volume":"101","author":"Haberichter","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2019111808512889400_B38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1073\/pnas.0710079105","article-title":"Assembly of Weibel-Palade body-like tubules from N-terminal domains of von Willebrand factor.","volume":"105","author":"Huang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"2019111808512889400_B39","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2009-07-226324","article-title":"A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A\/IIE.","volume":"115","author":"Schneppenheim","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111808512889400_B40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2003.00435.x","article-title":"Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues.","volume":"2","author":"Tjernberg","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"40","key":"2019111808512889400_B41","doi-asserted-by":"crossref","first-page":"15647","DOI":"10.1073\/pnas.0705175104","article-title":"Two Cys residues essential for von Willebrand factor multimer assembly in the Golgi.","volume":"104","author":"Purvis","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111808512889400_B42","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1365-2141.2005.05375.x","article-title":"The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype.","volume":"128","author":"Bowen","year":"2005","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111808512889400_B43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood-2003-05-1505","article-title":"An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13.","volume":"103","author":"Bowen","year":"2004","journal-title":"Blood"},{"issue":"10","key":"2019111808512889400_B44","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood.V98.10.2973","article-title":"Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins.","volume":"98","author":"Bod\u00f3","year":"2001","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/19\/4543\/1352759\/zh801912004543.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/19\/4543\/1352759\/zh801912004543.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T07:56:29Z","timestamp":1641369389000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/19\/4543\/30006\/Intersection-of-mechanisms-of-type-2A-VWD-through"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,10]]},"references-count":44,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2012,5,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-06-360875","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,10]]}}}